[Pruritus: physiopathology. Therapeutic attempts].
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D002792:Cholestyramine Resin / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D009475:Neurons, Afferent / Q000502:physiology; D010146:Pain / Q000503:physiopathology; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D011984:Sensory Receptor Cells / Q000502:physiology; D012867:Skin / Q000294:innervation; D013116:Spinal Cord / Q000503:physiopathology; D009435:Synaptic Transmission
D014151:Anti-Anxiety Agents; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D002792:Cholestyramine Resin; D009270:Naloxone
Le prurit: physiopathologie. Applications thérapeutiques.